Untitled Document click here to view Pharma-2012

pharma_menu

                 

    OMICS Group’s
    International Conference and Exhibition on Pharmaceutical Regulatory Affairs


    Theme: Research & Advancements in Pharmaceutical Regulatory Affairs

    Dates: 6-7 September 2011

    Venue: BWI Airport Marriott, Baltimore, Maryland, USA

             Tel:                                Fax:                             Toll Free:
    +1-650-268-9744           +1-650-618-1414               +91-040-40131662

    Website:
    https://www.omicsonline.org/pharma2011/

    Submit Your Abstract Online at:

    https://www.omicsonline.org/pharma2011/abstract.php 

    (OR) e-mail to: pharma2011@omicsonline.org

    We warmly invite you to attend and submit your abstract to the most important The International Conference and Exhibition on Pharmaceutical Regulatory Affairs.


    Pharma-2011 is comprised of 7 tracks and 28 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutical Regulatory Affairs. Please submit your abstract to any of the following track.

    Track 1: Regulatory Affairs for Drugs
    Track 1.1: Regulatory Aspects of Biotechnological Products
    Track 1.2: Quality Assurance/Quality Risk Management
    Track 1.3: Clinical Trials in Emerging Markets
    Track 1.4: Drug Regulatory Affairs
    Track 2: Biologics and Medical Devices
    Track 2.1: Clinical Trial Design for Medical Devices
    Track 2.2: Biologics & Design Control
    Track 2.3: Process Validation for Drugs and Biologics
    Track 2.4: Bioengineered Pharmaceutical Products
    Track 3: Drug Designing & Development
    Track 3.1: Drug Metabolism in Drug Discovery and Development
    Track 3.2: Analytical Method Validations
    Track 3.3: Epidemiology of Drug-Drug Interactions
    Track 3.4: Biochemical Mechanisms of Drug Toxicity
    Track 4: Safety and Quality Regulation
    Track 4.1: Safety and efficacy of prescription drugs
    Track 4.2: Training Needs in Regulatory Science for the Biopharmaceutical Industry
    Track 4.3: Drug Labelling Regulations
    Track 4.4: Good regulatory practices
    Track 5: Regulatory Affairs: Compliances
    Track 5.1: Regulatory Environment: Clinical Trials
    Track 5.2: Quality System Frame Work for Pharmaceutical Products
    Track 5.3: Regulatory Aspects of NDA and ANDA: Regulatory Filing and Submissions
    Track 5.4: Development and Updates of the Pharmaceutical Regulatory Systems
    Track 6: Product Manufacturing Procedures
    Track 6.1: Good manufacturing pratices
    Track 6.2: Environmental Aspects
    Track 6.3: Types of Production activities
    Track 6.4: Methods to Enhance Product Quality
    Track-7: Advances in Gene therapy
    Track 7-1 : Human Gene Therapy (Human Genome Project)
    Track 7-2 : Viral vectors and Gene Therapy
    Track 7-3 : Genetic Screening & DNA Testing
    Track 7-4 : Development in Cell Cloning
    Participants list Academic
    Untitled Document
    Tulane University, USA

    Stanford University, USA

    Texas A&M Health Science Center, USA

    University of Washington,USA

    University of Illinois, USA

    Van Andel Research Institute, USA

    Fourth Military Medical University, China

    Ohio State University, USA

    University at Albany, USA

    Harvard Medical School, USA

    University of Pittsburgh, USA

    Northeastern University, USA

    Thomas Jefferson University, USA

    Albert Einstein College of Medicine, USA

    UAE University, UAE

    Nankai University School of Medicine, China

    University of Milan, Italy

    Medicine Kuwait University, Kuwait

    Swiss Institute of Bioinformatics, Switzerland

    University of Pittsburgh, USA

    National Cancer Institute, USA

    Wake Forest University, China

    Navy General Hospital, China

    University of Texas, USA

    St.Petersburg State University, Russia

    Seoul National University, South Korea

    University of Wisconsin-Madison,USA

    Ecole Polytechnique, Canada

    Boys Town National Research Hospital, USA

    University of Pittsburgh, USA

    Academy of Sciences of the Czech Republic, Czech Republic

    New Jersey Institute of Technology, USA

    International Stem Cell Corporation, USA

    University of Minho, Portugal

    Virginia University, USA

    UMDNJ-Robert Wood Johnson Medical School, USA

    Keio university, Japan

    Sanford Burnham Medical Research Institute, USA

    State University of New York Downstate Medical Center, USA

    Cornell University, USA

    Radboud University Nijmegen Medical Centre, Netherlands

    Participants list Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women’s Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy’s labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     

    Operated by: Editors - Journal of Bioequivalence & Bioavailability , Journal of Bioanalysis & Biomedicine

    Hosting Organization : OMICS Publishing Group